122 related articles for article (PubMed ID: 3325818)
1. IgG subclass antibody markers in grass pollen immunotherapy.
Moss RB
N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
[TBL] [Abstract][Full Text] [Related]
2. Isotypic and antigenic restriction of the blocking antibody response to ryegrass pollen: correlation of rye group I antigen-specific IgG1 with clinical response.
Moss RB; Hsu YP; Kwasnicki JM; Sullivan MM; Reid MJ
J Allergy Clin Immunol; 1987 Feb; 79(2):387-98. PubMed ID: 3819220
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass antibodies in response to house dust mite immunotherapy.
Nakagawa T
N Engl Reg Allergy Proc; 1987; 8(6):423-8. PubMed ID: 3481430
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
Malling HJ; Djurup R
Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
Djurup R; Osterballe O
Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
7. A computational approach to the description of individual immune responses. IgE and IgG-subclass allergen-specific antibodies formed during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1991 Jan; 46(1):10-9. PubMed ID: 2018204
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
[TBL] [Abstract][Full Text] [Related]
9. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
11. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model.
Michils A; Vervier I; Choufani G; Gossart B; Duchateau J
Clin Exp Allergy; 1999 Jun; 29(6):832-9. PubMed ID: 10336601
[TBL] [Abstract][Full Text] [Related]
12. Purification of human IgG4 subclass with allergen-specific blocking activity.
Lambin P; Bouzoumou A; Murrieta M; Debbia M; Rouger P; Leynadier F; Levy DA
J Immunol Methods; 1993 Sep; 165(1):99-111. PubMed ID: 8409473
[TBL] [Abstract][Full Text] [Related]
13. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
[TBL] [Abstract][Full Text] [Related]
14. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.
Devey ME; Wilson DV; Wheeler AW
Clin Allergy; 1976 May; 6(3):227-36. PubMed ID: 939035
[TBL] [Abstract][Full Text] [Related]
15. The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children.
Wang JY; Lei HY; Hsieh KH
Asian Pac J Allergy Immunol; 1992 Jun; 10(1):11-8. PubMed ID: 1418178
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Mothes N; Heinzkill M; Drachenberg KJ; Sperr WR; Krauth MT; Majlesi Y; Semper H; Valent P; Niederberger V; Kraft D; Valenta R
Clin Exp Allergy; 2003 Sep; 33(9):1198-208. PubMed ID: 12956739
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
[TBL] [Abstract][Full Text] [Related]
18. The subclass of IgG antibody in allergic disease: II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals.
Kemeny DM; Urbanek R; Ewan P; McHugh S; Richards D; Patel S; Lessof MH
Clin Exp Allergy; 1989 Sep; 19(5):545-9. PubMed ID: 2790562
[TBL] [Abstract][Full Text] [Related]
19. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.
van der Giessen M; Homan WL; van Kernbeek G; Aalberse RC; Dieges PH
Int Arch Allergy Appl Immunol; 1976; 50(5):625-40. PubMed ID: 773842
[TBL] [Abstract][Full Text] [Related]
20. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome.
Gehlhar K; Schlaak M; Becker W; Bufe A
Clin Exp Allergy; 1999 Apr; 29(4):497-506. PubMed ID: 10202364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
